Literature DB >> 8283255

Meningiomas: a quest for the optimum therapy.

S A Newman.   

Abstract

Entities:  

Mesh：

Year:  1994        PMID： 8283255     DOI： 10.3171/jns.1994.80.2.0191

Source DB:  PubMed          Journal:  J Neurosurg        ISSN： 0022-3085            Impact factor:   5.115


× No keyword cloud information.
  6 in total

Review 1.  Prolonged oral hydroxyurea and concurrent 3d-conformal radiation in patients with progressive or recurrent meningioma: results of a pilot study.

Authors:  Barbara M Hahn; Ulrich M H Schrell; Rolf Sauer; Rudolf Fahlbusch; Oliver Ganslandt; Gerhard G Grabenbauer
Journal:  J Neurooncol       Date:  2005-09       Impact factor: 4.130

2.  Petroclival meningiomas: is radical resection always the best option?

Authors:  J Zentner; B Meyer; U Vieweg; C Herberhold; J Schramm
Journal:  J Neurol Neurosurg Psychiatry       Date:  1997-04       Impact factor: 10.154

3.  Gamma Knife Stereotactic Radiosurgery for Grade 2 Meningiomas.

Authors:  Tamer Refaat; Michelle Gentile; Sean Sachdev; Prarthana Dalal; Anish Butala; Stanley Gutiontov; Irene Helenowksi; Plato Lee; Vythialinga Sathiaseelan; Orin Bloch; James Chandler; John A Kalapurakal
Journal:  J Neurol Surg B Skull Base       Date:  2017-02-01

4.  [The results of radiotherapy in meningiomas with a high risk of recurrence. A retrospective analysis].

Authors:  C Winkler; S Dornfeld; R Schwarz; S Friedrich; M Baumann
Journal:  Strahlenther Onkol       Date:  1998-12       Impact factor: 3.621

Review 5.  Treatment of meningioma: an update.

Authors:  Anthony L D'Ambrosio; Jeffrey N Bruce
Journal:  Curr Neurol Neurosci Rep       Date:  2003-05       Impact factor: 5.081

6.  Comparison of intensity modulated radiotherapy (IMRT) with intensity modulated particle therapy (IMPT) using fixed beams or an ion gantry for the treatment of patients with skull base meningiomas.

Authors:  Katsura Kosaki; Swantje Ecker; Daniel Habermehl; Stefan Rieken; Oliver Jäkel; Klaus Herfarth; Jürgen Debus; Stephanie E Combs
Journal:  Radiat Oncol       Date:  2012-03-22       Impact factor: 3.481
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.